Form 483

Tris Pharma Inc. Form 483, 2025-11-21

FDA issued a Form 483 to Tris Pharma Inc. on 2025-11-21 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Tris Pharma Inc. · Monmouth Junction, United States · Issued November 21, 2025

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Nov 2025
21 CFR 211.192

Investigations of discrepancies, failures

Cited by James R Birkenstamm

Inspected site

TPTris Pharma Inc.Monmouth Junction, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere